Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jin Li
Age : 52
Country of residence : Unknown
Linked companies : China State Construction Engineering Corporation Limited

Biography of Jin Li 
Presently, Jin Li is Executive Vice President-Engineering at Zoina T-Park Group Holdings Ltd.


Current positions of Jin Li 
Jin Li : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Jin Li : Connections 


Latest news about Jin Li 
09/06Guosen Securities Co., Ltd. Announces Director Appointments
CI
08/20Ping An Insurance Company of China, Ltd Announces Directors Appointments
CI
05/17YFY Inc. Announces Executive Changes
CI
05/17YFY Inc. Announces Board Changes
CI
04/16Certain A Shares of HitGen Inc. are subject to a Lock-Up Agreement Ending on 16-APR-2021.
CI
03/28Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint
CI
03/25Ping An Insurance Company of China, Ltd. Approves Board Appointments
CI
More news